Department of Emergency Medicine, Lanzhou University Second Hospital, Lanzhou, Gansu, China.
Department of Gastroenterology, The Second Provincial People's Hospital of Gansu, Lanzhou, Gansu, China.
Dis Markers. 2020 Jan 19;2020:8140989. doi: 10.1155/2020/8140989. eCollection 2020.
Actin filament-associated protein 1-antisense RNA 1 (AFAP1-AS1) plays an important role in the development and progression of several human cancers. However, its biological function in gastric cancer (GC) progression is still unknown.
We used qRT-PCR to detect the relative expression of AFAP1-AS1 in GC tissues and cell lines. The loss-of-function assays were conducted to detect the effect of AFAP1-AS1 on GC development. Bioinformatics analysis, luciferase reporter gene analysis, and RIP analysis were used to identify and validate target genes of AFAP1-AS1. Finally, rescue tests were performed to confirm the influence of the AFAP1-AS1-miR-155-5p-FGF7 axis on GC development.
AFAP1-AS1 was upregulated in GC tissues and cell lines and was closely correlated with poor prognosis of GC patients. AFAP1-AS1 knockdown inhibited proliferation, migration, and invasion of GC cells, indicating that AFAP1-AS1 acts as an oncogene in GC. Bioinformatics analysis, dual-luciferase reporter gene detection, and RIP assays validated that AFAP1-AS1 directly interacts to miR-155-5p and could positively affect cell proliferation, migration, and invasion by regulation of the expression of miR-155-5p and FGF7. Further rescue assays revealed that AFAP1-AS1 promotes cell proliferation and metastasis through the miR-155-5p/FGF7 axis in GC.
AFAP1-AS1 might be an oncogenic lncRNA that promoted GC progression by acting as a competing endogenous RNA (ceRNA) that regulates the expression of FGF7 through sponging miR-155-5p, suggesting that AFAP1-AS1 may be a novel potential therapeutic target for GC.
肌动蛋白丝相关蛋白 1 反义 RNA 1(AFAP1-AS1)在几种人类癌症的发生和发展中发挥着重要作用。然而,其在胃癌(GC)进展中的生物学功能尚不清楚。
我们使用 qRT-PCR 检测 GC 组织和细胞系中 AFAP1-AS1 的相对表达。通过功能丧失实验检测 AFAP1-AS1 对 GC 发生发展的影响。生物信息学分析、荧光素酶报告基因分析和 RIP 分析用于鉴定和验证 AFAP1-AS1 的靶基因。最后,进行挽救实验以确认 AFAP1-AS1-miR-155-5p-FGF7 轴对 GC 发生发展的影响。
AFAP1-AS1 在 GC 组织和细胞系中上调,与 GC 患者的不良预后密切相关。AFAP1-AS1 敲低抑制 GC 细胞的增殖、迁移和侵袭,表明 AFAP1-AS1 在 GC 中发挥癌基因作用。生物信息学分析、双荧光素酶报告基因检测和 RIP 实验验证了 AFAP1-AS1 与 miR-155-5p 直接相互作用,并通过调节 miR-155-5p 和 FGF7 的表达,可正向影响细胞增殖、迁移和侵袭。进一步的挽救实验表明,AFAP1-AS1 通过 miR-155-5p/FGF7 轴在 GC 中促进细胞增殖和转移。
AFAP1-AS1 可能是一种致癌 lncRNA,通过作为竞争性内源 RNA(ceRNA)发挥作用,通过海绵吸附 miR-155-5p 调节 FGF7 的表达,促进 GC 进展,提示 AFAP1-AS1 可能是 GC 的一种新的潜在治疗靶点。